These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10946322)

  • 1. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis.
    Griffith TS; Anderson RD; Davidson BL; Williams RD; Ratliff TL
    J Immunol; 2000 Sep; 165(5):2886-94. PubMed ID: 10946322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL).
    Routes JM; Ryan S; Clase A; Miura T; Kuhl A; Potter TA; Cook JL
    J Immunol; 2000 Oct; 165(8):4522-7. PubMed ID: 11035092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.
    Voelkel-Johnson C; King DL; Norris JS
    Cancer Gene Ther; 2002 Feb; 9(2):164-72. PubMed ID: 11857034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
    Lamothe B; Aggarwal BB
    J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
    Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
    J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.
    Armeanu S; Lauer UM; Smirnow I; Schenk M; Weiss TS; Gregor M; Bitzer M
    Cancer Res; 2003 May; 63(10):2369-72. PubMed ID: 12750253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
    Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
    J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus.
    Washburn B; Weigand MA; Grosse-Wilde A; Janke M; Stahl H; Rieser E; Sprick MR; Schirrmacher V; Walczak H
    J Immunol; 2003 Feb; 170(4):1814-21. PubMed ID: 12574346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
    J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.
    Thomas WD; Hersey P
    J Immunol; 1998 Sep; 161(5):2195-200. PubMed ID: 9725211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.
    Kemp TJ; Elzey BD; Griffith TS
    J Immunol; 2003 Jul; 171(1):212-8. PubMed ID: 12817000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
    Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
    Liu S; Yu Y; Zhang M; Wang W; Cao X
    J Immunol; 2001 May; 166(9):5407-15. PubMed ID: 11313377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.
    Chawla-Sarkar M; Leaman DW; Jacobs BS; Borden EC
    J Immunol; 2002 Jul; 169(2):847-55. PubMed ID: 12097388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.
    VanOosten RL; Earel JK; Griffith TS
    Cancer Gene Ther; 2006 Jun; 13(6):628-32. PubMed ID: 16456549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
    Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
    Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.